Dyck
Pages
-
-
1977 AMP Tercian
-
Psychiatric stabilizer. Regulates; affect, thymia, the neuro vegetative sphere., Cyamepromazine 25, Theraplix, Black and White, text along left side, center: image of circle (presumably the sun) and three birds in flight (grey, composed entirely of shaded lines, features not discernable). Full page, image is central
-
-
1977 AMP Tranxene
-
In high doses Traxene exercises; a major anxiolytic effect, a sedative effect that reduces agitation, a favourable effect on neurotic and contemporaneous insomnia. For anxiety and anguish with or without agitation, in neurosis, depression, certain cases of psychosis, alcoholism, Laboratoires Clin-Comar, Black a white image covers most of page: one larger bottle of pills with two loose pills next to the bottle, behind and slightly to the left is a bottle of the drug in solution form, a vial and a syringe. Fine print in a column on the right. Full page, image dominates the ad
-
-
1977 AMP Urbanyl
-
Urbanyl in psychiatry, urbanyl in general medicine. Anxiety and psychotic states, neurotic anxiety, angst, anxious tension, worries, normal. Urbanyl, an anxiolytic for active people. Daytime, restores vigilance. Nightime improves quality of rest., Clobazam, Laboratoires Diamant, Scale with different shades of blue indicates severity of anxiety. The label "Urbanyl for psychiatric use" is towards the saturated blue end while "urbanyl for general medicine" is towards the light blue end. Fine print below. Full page
-
-
1977 AMP Urbanyl
-
Major anxiolytic with great maneuverability. Suppresses anxiety and restores normal activity., Clobazam, Laboratoires Diamant, Blue background, bold white print for slogan and brand name, half page white text box contains fine print. Full page
-
-
1977 AMP Vivalan
-
Uses: for depressed states regardless of severity or type: psychotic, neurotic or reactional. Psychotic and melancholic depression, depression in psychotic manic depressive illness, melancholy of involution, reactional depression, post-traumatic depression, Viloxazine, ICI Pharma, Bold brand name at top, center is mostly blank (no text or images),bottom two columns of fine print separated by a flower pot, flower is abstract in design made up of triangle segments. Full page, mostly text and one small graphic, much of the page is blank
-
-
1977 ANZJP Dalmame
-
The closest approach to a No risk sleep medication. "Flurazepam is probably the least hazrdous of hypnotic durgs with respect to the danger of abuse or overdose. Provides sleep, on average, in 17 minutes. Provides sleep with fewer night-time awakenings. Provides sleep with little morning "hang-over". Consistently effective when prolonged administration is necessary without increased dosage., Flurazepam, Roche Products Pty. Limited., Prescription pad with the drug name on it, picture of a hand holding a pen, picture of the tablets.
-
-
1977 ANZJP Droleptan
-
For control of acute agitation, Droperidol, Ethnor, Background of pink triangular brush strokes all pointing downwards.
-
-
1977 ANZJP Loxapac
-
Lederle introduce Loxapac. A new effective chemical entity for the manifestations of acute and chronic schizophrenia… Loxapax is a dibenzoxazepine representing a new subclass of tricyclic antipsychotic agents. It is chemically distinct from the phenothiazines, thioxanthenes and butyrophenones. Controlled studies with large patient groups not only show the efficacy of Loxapac but significantly indicate certain favourable trends in the Loxapac side effect profile., Loxapine Succinate, Ctanamid, Person with white clown make up on, clutching hands to chest/neck, looking straight up with eyes wide open.
-
-
1977 ANZJP Orap
-
Disabling side effects a problem for… Patient - adding drug-induced sedation and other physical problems to the ambulatory schizophrenic's already heavy burden can only lessen the patient's prospects for a better life. Family - disturbing drug-induced side effects can provoke embarrassment and shame among family and friends and contribute to the deterioration of family relationships so often seen when the schizophrenic lives at home. Physician - the need to limit the dosage of certain neuroleptics - dur to the emergence of disabling side effects - has been a continuing problem to the physician treating the ambulatory schizophrenic. To help the ambulatory schizophrenic function more normally, Orap tablets exhibit minimal disabling side effects. The normal maintenance dosage levels of Orap exhibit virtually no hypnosedative action nor are disabling autonomic or extrapyramidal effects generally seen in the effective range. With their physical and mental capacity relatively unimpaired, patients build up self-confidence. They feel they have the capacity to cope and to become functioning, productive members of the community., Ethnor, All green silhouette of a person (male) in a wheelchair.
-
-
1977 ANZJP Orap
-
Apathy and indifference a problem for the… Patient - idle and unreliable, unwilling and unable to bear daily responsibilities, the apathetic, indifferent patient's prospects for a better life are not very good. Family - the emotional and practical problems that can result from the presence of an idle, irresponsible schizophrenic in the family can, and often do, reach the very limit of what is tolerable for the family and patient alike. Physician - the patient who is apathetic and indifferent to seeing his physician adds greatly to the difficulties of monitoring his progress and loses the real therapeutic value that results from your expression of interest and concern. To help the ambulatory schizophrenic function more normally Orap tablets activate the apathetic individual. Patients who are apathetic and indifferent often become more open and cheerful and show a marked change in initiative and motivation to work. The willingness to work and ability to perform constitute an important step toward social acceptability and reintegration into the community., Ethnor, All blue silhouette of a person (female) sitting in a wheelchair.
-
-
1977 ANZJP Orap
-
Emotional withdrawal a problem for the…Patient isolated, alone, unable to form working relationships with family, friends or co-workers, the emotionally withdrawn patient's prospects for a better life ar not very good. …Family The emotional and practical problems that can result from the presence of an emotionally withdrawn schizophrenic in the family can, and often do, reach the very limit of what is tolerable for family and patient alike. …Physician The patient who will not venture out and misses or postpones seeing his physician adds greatly to the difficulties of monitoring his progress and loses the real theraputic value that results from your expression of interest and concern. To help the ambulatory schizophrenic function more normally Orap Tablets effectively reduce emotional withdrawal. Patients on orap often exhibit remarkable improvements in sociability. They become more communicative, co-operative and open, and show an imprved capacity to adapt to their environment. They fit in better with family, friends and co-workers and stand to gain more out programs directed toward their social and occupational rehabilitation. Emotional withdrawal was completely eliminated in 43% of the pimozide-treated patients exhibting this symptom but in none of the chlorpromazine-treated patients. Appreciable gains are then noted not only on antipsychotic activity but especially in social opennes with positive changes of attitude in terms of spontaneous social behaviour. In outpatients with paranoia or paranoid personality structures, primozide not only produces insight but also awareness by the patient of himself, others and the outside world. The resulting introspection, consciousness and self-direction lead to improved social behaviour and achievements., Primozide, Janssen Pharmaceutica Research Labs. Ethnor PTY LTD, Blue silhouette of an isolate male from a group of three other blue silhouettes.
-
-
1977 ANZJP Parnate
-
Not every road has a nasty turning for many patients, depression can be a one-way street with suicide as its ending. Because of this, anti-depressant therapy must not only be effective, by also rapid in its onset of action. Even moderate delays between prescribing and theraputic effect can have tragic consequences. Parnate acts rapidly; often relieving moderate to severe depression in as little as 1 to 3 days. The patient feels better faster-and the danger of suicide is greatly diminished. The rapid action also means that parnate gives the physician an early indication of therapeutic effect, allowing psychotherapy to being almost immediately. Parnate - the faster therapeutic response in depression., Tranylcypromine, Smith Kline & French Laboratories (Australia) Limited., Black & White image of a one way street.
Pages
